Psychiatry Research
Volume 125, Issue 3 , Pages 185-191 , 15 March 2004

Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population

  • Alda M Ambrósio

      Affiliations

    • Department of Neurochemistry, Faculty of Medicine, Center for Neuroscience of Coimbra, University of Coimbra, 3004-517 Coimbra, Portugal
    • Corresponding Author InformationCorresponding author. Tel.: +351-239-820190; fax: +351-239-822776
    • ,
  • James L Kennedy

      Affiliations

    • Neurogenetics Section, Center for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • Fabio Macciardi

      Affiliations

    • Neurogenetics Section, Center for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
    • ,
  • António Macedo

      Affiliations

    • Department of Psychological Medicine, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    • ,
  • José Valente

      Affiliations

    • Department of Psychological Medicine, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    • ,
  • Ana Dourado

      Affiliations

    • Department of Psychological Medicine, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    • ,
  • Catarina R Oliveira

      Affiliations

    • Department of Neurochemistry, Faculty of Medicine, Center for Neuroscience of Coimbra, University of Coimbra, 3004-517 Coimbra, Portugal
    • ,
  • Carlos Pato

      Affiliations

    • Center for Psychiatric and Molecular Genetics, SUNY Upstate Medical University and Behavioral Health Care Line, VISN 2, Veterans Administration, Syracuse, NY, USA

Received 27 February 2003 ,Revised 23 September 2003 ,Accepted 22 December 2003.

References 

  1. Arinami T, Itokawa M, Aoki J, Shibuya H, Ookubo Y, Iwawaki A, et al. Further association study of the dopamine D2 receptor variant S311C in schizophrenia and affective disorders. American Journal of Medical Genetics. 1996;67:133–138
  2. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet. 1994;343:703–704
  3. Breen G, Brown J, Maude S, Fox H, Collier D, Li T, et al. −141C Del/Ins polymorphism of the dopamine receptor 2 gene is associated with schizophrenia in a British population. American Journal of Medical Genetics. 1999;88:407–410
  4. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annual Review of Pharmacology and Toxicology. 2001;41:237–260
  5. Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao K-J. Further evidence of no association between Ser 9 Gly polymorphism of dopamine D3 receptor gene and schizophrenia. American Journal of Medical Genetics. 1997;74:40–43
  6. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. American Journal of Human Genetics. 1999;65:1170–1170
  7. Di Bella D, Catalano M, Strukel A, Nobile E, Smeraldi E. Distribution of the MscI polymorphism of the dopamine D3 receptor in an Italian psychotic population. Psychiatric Genetics. 1994;4:39–42
  8. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz J-C, Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. American Journal of Medical Genetics. 1998;81:318–322
  9. Grandy DK, Litt M, Allen LJ, Bunzow J, Magenis RE, Civelli O. Dopamine D2 receptor maps to human chromosome 11q22–q23 and identifies a TaqI RFLP. Cytogenetics and Cell Genetics. 1989;51:1007
  10. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Human Molecular Genetics. 1993;2:2197
  11. Himei A, Koh J, Sakai J, Inada Y, Akabame K, Yoneda H. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and −141C Ins/Del polymorphisms. Psychiatry and Clinical Neuroscience. 2002;56:97–102
  12. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. American Journal of Medical Genetics. 2001;105:774–778
  13. Itokawa M, Arinami T, Futamura N, Hamaguchi H, Toru M. A structural polymorphism of human dopamine D2 receptor D2 (Ser311Cys). Biochemical and Biophysical Research Communications. 1993;3:1369–1375
  14. Jönsson EG, Lanfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatrica Scandinavica. 1993;87:345–349
  15. Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, et al. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophrenia Research. 1999;40:31–36
  16. Jönsson EG, Sillen A, Vares M, Ekholm B, Terenius L, Sedvall GC. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. American Journal of Medical Genetics. 2003;119B:28–34
  17. Jönsson EG, Flyckt L, Burgert E, Crocq M-A, Forslund K, Mattila-Evenden M, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric Genetics. 2003;13:1–12
  18. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, et al. Association study of dopamine D3 receptor gene and schizophrenia. American Journal of Medical Genetics. 1995;60:558–562
  19. Kremer I, Rietschel M, Dobrusin M, Mujaheed M, Murad I, Blanaru M, et al. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. American Journal of Medical Genetics. 2000;96:778–780
  20. Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jönsson E, et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigation psychiatric disorders. Psychiatric Genetics. 1992;2:249–256
  21. Le Coniat M, Sokoloff P, Hillion J, Martres MP, Giros B, Pilon C. Chromosomal localization of the human D3 dopamine receptor gene. Human Genetics. 1991;87:618–620
  22. Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, et al. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 1998;32:87–92
  23. Macciardi F, Verga M, Kennedy JL, Petronis A, Giuseppe B. An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using the haplotype relative risk. Human Heredity. 1994;44:328–336
  24. Mant R, Williams J, Asherson P. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. American Journal of Medical Genetics. 1994;54:21–27
  25. McGuffin P, Owen MJ, Farmer AE. The genetic basis of schizophrenia. Lancet. 1995;346:678–682
  26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988;16:1215
  27. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiological Reviews. 1998;78:189–225
  28. Morimoto K, Miyatake R, Nakamura M, Watanabe T, Hirao T, Suwaki H. Delusional disorder: molecular genetic evidence for dopamine psychosis. Neuropsychopharmacology. 2002;26:794–801
  29. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A. Association study of schizophrenia with dopamine D3 receptor gene polymorphisms: probable effects of family history of schizophrenia?. American Journal of Medical Genetics. 1993;48:214–217
  30. Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonkar VL, Thelma BK. Association study of schizophrenia among Indian families. American Journal of Medical Genetics. 1999;88:298–300
  31. Rothschild LG, Badner J, Cravchik A, Gershon ES, Gejman PV. No association detected between a D3 receptor gene-expressed variant and schizophrenia. American Journal of Medical Genetics. 1996;67:232–234
  32. Sasaki T, Macciardi FM, Badri F, Verga M, Meltzer HY, Lieberman J, et al. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis. American Journal of Medical Genetics. 1996;67:415–417
  33. Schindler K, Torre CD, Bauer A, Medeiros H, Carvalho C, Fernandes LF, et al. Identification of a highly homogenous population for genetic study of psychiatric disorders. CNS Spectrums. 1999;4:22–24
  34. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, et al. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics. 1996;97:714–719
  35. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990;347:146–151
  36. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. American Journal of Human Genetics. 1998;62:450–458
  37. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics. 1993;52:506–516
  38. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European multicentre association study of schizophrenia: a study of the DRD2 Ser 311Cys and DRD3 Ser 9Gly polymorphisms. American Journal of Medical Genetics. 1998;81:24–28
  39. Tanaka T, Igarashi S, Onodera O, Tanaka H, Fukushima N, Takahashi M, et al. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. American Journal of Medical Genetics. 1996;67:208–211
  40. Terwilliger JD, Ott J. A haplotype-based ‘Haplotype Relative Risk’ approach to detecting allelic associations. Human Heredity. 1992;42:337–346
  41. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Molecular Psychiatry. 1998;3:141–149
  42. Yang L, Li T, Wiese C, Lannfelt L, Sokoloff P, Xu CT, et al. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. American Journal of Medical Genetics. 1993;48:83–86

PII: S0165-1781(04)00003-4

doi: 10.1016/j.psychres.2003.12.016

Psychiatry Research
Volume 125, Issue 3 , Pages 185-191 , 15 March 2004

Article Tools